Search Results 1561-1570 of 14752 for anti-TNF drugs

  1. Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma - Mayo Clinic

    By condition, treatment or drug name. Search tips ... Drugs used in chemotherapy, such as ... anti-CD20 monoclonal antibody), as measured from ...

  2. Factor Xiii (Intravenous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Corifact; Tretten. Descriptions. Factor ...

  3. Efficacy and Safety of REC-2282 in Participants with Progressive NF2 Mutated Meningiomas (POPLAR-NF2) - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... screening. 3. Received an anti- tumor agent for meningioma within 3 ...

  4. The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) - Mayo Clinic

    ... treatment (including both insulin dependent and non-insulin dependent diabetes mellitus); Current or past use of insulin or any other anti-diabetic medication ...

  5. LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma - Mayo Clinic

    About this study. The primary purpose of this study is to assess the anti-tumor activity of LGX818/MEK162 in combination with targeted agents after ...

  6. Retrospective study finds that cancer drug also lowers blood glucose - Mayo Clinic News Network

    ROCHESTER, Minnesota — Dasatinib, a drug that often is used to treat certain types of leukemia, may have antidiabetic effects comparable to medications used ...

  7. Ado-Trastuzumab Emtansine (Intravenous Route) Description and Brand Names - Mayo Clinic

    It is also used as additional treatment in patients with HER2-positive early breast cancer who have cancer left after a taxane medicine and trastuzumab-based ...

  8. XmAb®20717 Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

    ... therapy; or arthritis that is managed without systemic therapy beyond oral acetaminophen and nonsteroidal anti-inflammatory drugs) * Have any condition ...

  9. A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma - Mayo Clinic

    The antibody is used to recognize tumor cells so the anti-cancer drug can kill them. Participation eligibility. Participant eligibility includes age, gender, ...

  10. Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index - Mayo Clinic

    An algorithm for a CTC-Endocrine Therapy Index (CTC-ETI) has been constructed that can be calculated for each patient using the CTC enumeration and marker ...